在神经分泌功能障碍中使用生长激素治疗
Ebru Barsal Çetiner1, Zeynep Donbaloğlu1, Berna Singin1
1Department of Pediatric Endocrinology, Akdeniz University Hospital, Antalya, Türkiye.
Turkish archives of pediatrics
|May 12, 2025
概括
用复合人体生长激素 (rhGH) 治疗生长激素神经分泌功能障碍 (GH-NSD) 显著改善了身高速度和最终身高. 患有GH-NSD的患者通过rhGH疗法实现了他们的遗传身高潜力.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 遗传学 遗传学 是一个
- 增长障碍 发展障碍 发展障碍
背景情况:
- 增长激素神经分泌功能障碍 (GH-NSD) 是一种罕见的疾病,导致人体矮小.
- 诊断包括评估夜间生长激素分泌与正常刺激测试一起.
- 重组人体生长激素 (rhGH) 是对GH-NSD的潜在治疗方法.
研究的目的:
- 评估接受rhGH的GH-NSD患者的治疗反应和最终身高.
- 分析第一年和第二年治疗结果.
- 评估基线参数与治疗反应之间的相关性.
主要方法:
- 对被诊断患有GH-NSD的18名患者进行了回顾性研究.
- 基线参数的评估:IGF-1,GH刺激测试,睡眠期间GH的平均值,身高SDS,MPH和PAH.
- 分析1年,2年和最终身高的治疗反应 (身高速度,身高SDS).
主要成果:
- rhGH疗法改善了GH-NSD患者的身高速度和整体身高.
- 平均基线高度SDS为-3.13;治疗后,最终高度SDS的平均值为-1.72.
- 在治疗的第一年和第二年观察到身高SDS的显著改善.
结论:
- 患有GH-NSD的患者表现出对rhGH治疗的积极反应.
- rhGH治疗有助于患者达到预测的遗传身高潜力.
- 基线身高SDS,预测成年人身高SDS和中期父母身高SDS与第一年身高速度相关.
更多相关视频
相关概念视频
Major Hormones and Their Functions
281
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
281
Hypoglycemia and Glucagon
148
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
148
Regulation of Hormone Secretion
3.0K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
Humoral...
3.0K
Hormones of the Pituitary Gland
6.2K
The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
6.2K
Hormones and Bone Tissue
2.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
Glucagon-like Receptor Agonists
289
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
289


